Linagliptin 5 mg medicine works by blocking the enzyme dipeptidyl peptidase-4 (DPP-4), which helps to control blood sugar levels by increasing insulin synthesis and decreasing glucose generation in the liver. According to studies, patients who use Linagliptin 5 mg experience significant reductions in HbA1c levels, which is an important predictor of long-term blood sugar control. In addition, when compared to other diabetic treatments, this medication has been proven to improve insulin sensitivity and lower the risk of hypoglycemia. Overall, Linagliptin 5 mg is a successful diabetic treatment option, allowing patients to manage their symptoms better.